HCSG at a glance
HEALTHCARE SERVICES GROUP INC (HCSG, SEC CIK 731012) filed its latest 10-K annual report on February 13, 2026, a 10-Q quarterly report on July 24, 2026, an 8-K current report on July 22, 2026 and Form 4 insider filings as recently as October 1, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), HEALTHCARE SERVICES GROUP INC (HCSG) reported revenue of $1.8 billion (up 7.1% from FY2024) and net income of $59.1 million. Diluted EPS was $0.81.
- As of June 30, 2026, 30 institutional investment managers tracked by SignalX reported holding HEALTHCARE SERVICES GROUP INC (HCSG) shares worth $936.3 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Kush Andrew on August 4, 2026 of 15,598 shares at $23.24 per share.
- In the last 90 days, HCSG insiders reported 0 open-market purchases ($0) and 1 open-market sale ($362K) on Form 4, a net sale of $362K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $1.8B
- +7.1% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$362K
- 13F holders
- 30 funds
- $936.3M · +1 vs prior quarter
- Latest 8-K
- Jul 22, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Risk Factors
- Cybersecurity incident Oct 9, 2024, causing class action litigation against the Company
- Executive VP Jason J. Bundick accountable for overall risk management including compliance and legal oversight
- Senior VP Jason Osbeck leads daily cybersecurity risk management since 2012 with IRP and Incident Response Team in place
- Audit Committee oversees cybersecurity risks reporting material issues to Board of Directors
- No disclosed exposure to geopolitical, supply chain, competitive, or financial risks in this section
Management Discussion & Analysis
- Revenue $1,837.2M, up 7.1% YoY; EVS $824.7M (7.7% increase), Dietary $1,012.5M (6.5% increase)
- Operating margin approx. 3.0% (Income before taxes $67.9M on $1,837.2M revenue, up from 3.1% to 3.7%)
- Best performing segment EVS revenue growth 7.7% to $824.7M, worst Dietary margin pressure with expenses up to 97.5% of revenue from 95.2%
- Net cash from operations $145M (up from $30.8M in 2024); $61.6M stock buybacks executed in 2025; Capex $5.8M; dividends not specified
- Management notes legislative risks impacting customer cash flow, aims for growth via new customers and pricing increases, amidst inflationary pressures on labor and supplies
AI summary of the HCSG 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Quarterly revenue $470.8M, up 2.7% YoY from $458.5M, driven by client wins, pricing and pass-through costs
- EVS strongest growth at $213.2M, up 3.6% YoY; Dietary $257.6M, up 1.9%
- Net margin 4.8% vs (7.0)% YoY; service-cost ratio 84.1% vs 99.4%
- Operating cash flow $65.6M for six months, up from $56.3M; liquidity $200.9M vs $203.9M
- Share repurchases $20.1M for 1.0M shares; tariffs had no material impact, with costs generally passed through to customers
Risk Factors
- New macroeconomic risk: Middle East conflicts increasing fuel, transportation and commodity-cost volatility
- Margin risk: Inflation in wages, food, supplies and services without effective contractual pass-throughs
- Operational risk: Cost increases could adversely affect cash flows and results of operations
- Financial risk: $19.885 million spent on repurchases during the quarter
AI summary of the HCSG 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 earnings announced for three months ended June 30, 2026
- Press release furnished as Exhibit 99.1, containing the substantive financial results
Item EX-99.1: Item EX-99.1
- Q2 revenue $470.8M, up from $458.5M; net income $22.7M versus a $32.4M loss
- Adjusted EBITDA $35.6M, or 7.6% of revenue, versus negative $36.3M and negative 7.9%
Item 5.07: Submission of Matters to a Vote of Security Holders
- Nine director nominees elected to one-year terms, preserving board continuity
- Say-on-pay proposal approved, with 61,059,063 votes for and 1,305,516 against
Item 2.02: Results of Operations and Financial Condition
- Q1 2026 earnings announcement for three months ended March 31, 2026
- Press release furnished as Exhibit 99.1, containing the reported financial results
Item EX-99.1: Item EX-99.1
- Q1 revenue $462.8M, up 3.4% YoY; mid-single-digit 2026 revenue growth outlook reiterated
- Net income $26.1M and diluted EPS $0.37, versus $17.2M and $0.23 in Q1 2025
AI summaries of HCSG 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for HCSG
Don't miss the next HCSG filing
- Alerts as it files. A push when HCSG files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut HCSG, by share count.
- Ask anything. An AI agent that reads every HCSG filing and answers with sources.
HCSG alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Simmons Kurt JR | A | Sep 30, 2026 | 734 | $20.45 |
| Grant Laura K | A | Sep 30, 2026 | 367 | $20.45 |
| WHALEN THOMAS GERARD | A | Sep 30, 2026 | 123 | $20.45 |
| Kush Andrew | Sell | Aug 4, 2026 | 15,598 | $23.24 |
| Brophy Andrew M | A | Jul 1, 2026 | 4,381 | - |
| Grant Laura K | A | Jun 30, 2026 | 306 | $24.56 |
| Grant Laura K | A | Jun 30, 2026 | 306 | $24.56 |
| WHALEN THOMAS GERARD | A | Jun 30, 2026 | 102 | $24.56 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $1.7B | $1.7B | $1.8B |
| Net Income | $38.4M | $39.5M | $59.1M |
| Net Margin | 2.3% | 2.3% | 3.2% |
| Balance Sheet | |||
| Total Assets | $790.7M | $802.8M | $794.3M |
| Equity | $456.6M | $499.9M | $510.2M |
| ROE | 8.4% | 7.9% | 11.6% |
| Per Share | |||
| EPS | - | $0.53 | $0.81 |
| Cash Flow | |||
| Operating CF | $43.5M | $30.8M | $145.0M |
| CapEx | $5.4M | $6.3M | $5.8M |
Source: XBRL data in HEALTHCARE SERVICES GROUP INC (HCSG)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate HCSG share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 30 | $936.3M |
| Q1 2026 | 29 | $697.2M |
| Q4 2025 | 27 | $650.3M |
| Q3 2025 | 29 | $617.3M |
| Q2 2025 | 29 | $555.9M |
| Q1 2025 | 26 | $262.1M |
| Q4 2024 | 21 | $260.7M |
| Q3 2024 | 18 | $128.5M |
- FMR LLC (Fidelity)+330.0K (+17%)
- Vanguard Portfolio Management LLC+234.2K (+5%)
- Invesco Ltd+168.2K (+20%)
- Citigroup+104.4K (+260%)
- State Street Corp+96.9K (+3%)
- Goldman Sachs Group−225.6K (-19%)
- Millennium Management−138.3K (-80%)
- Raymond James Financial−128.4K (-24%)
- AQR Capital Management−112.5K (-10%)
- D.E. Shaw & Co−84.4K (-24%)
- Citadel Advisors LLC+169.9K
- HANCOCK WHITNEY CORP+14.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 209 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
HCSG filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
8-K current reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Aug 5, 2026 | - | - | - |
| 10-Q | Jul 24, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 22, 2026 | - | Analysis | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | May 29, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 4 | May 28, 2026 | - | - | |
| 8-K | May 27, 2026 | - | Analysis | |
| SC 13G | Apr 30, 2026 | - | - | |
| SC 13G | Apr 29, 2026 | - | - | |
| 10-Q | Apr 24, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | Apr 22, 2026 | - | Analysis | - |
Related Health Care companies
- BKD · Brookdale Senior Living Inc.Services-Nursing & Personal Care Facilities
- SNDA · SONIDA SENIOR LIVING, INC.Services-Nursing & Personal Care Facilities
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
HCSG SEC filings: frequently asked questions
Are HCSG insiders buying or selling?
In the last 90 days, HEALTHCARE SERVICES GROUP INC (HCSG) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $362,498 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold HCSG stock?
As of June 30, 2026, the largest HEALTHCARE SERVICES GROUP INC (HCSG) holders among the 13F filers tracked by SignalX were BlackRock ($279.4 million), Vanguard Portfolio Management LLC ($124.8 million), Vanguard Capital Management LLC ($74.7 million), State Street Corp ($71.6 million), Dimensional Fund Advisors ($61.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was HCSG's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), HEALTHCARE SERVICES GROUP INC (HCSG) reported revenue of $1.8 billion (up 7.1% from FY2024) and net income of $59.1 million. Diluted EPS was $0.81. The figures come from the XBRL data in the 10-K.
What are the main risks in HCSG's latest 10-K?
In the 10-K filed February 13, 2026, HEALTHCARE SERVICES GROUP INC (HCSG) flagged: Cybersecurity incident Oct 9, 2024, causing class action litigation against the Company. Executive VP Jason J. Bundick accountable for overall risk management including compliance and legal oversight. (AI summary of the Risk Factors section.)
What did HCSG report in its latest 8-K?
HEALTHCARE SERVICES GROUP INC (HCSG) filed an 8-K on July 22, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 2026 earnings announced for three months ended June 30, 2026.
What are the latest HCSG SEC filings?
HEALTHCARE SERVICES GROUP INC (HCSG) filed its latest 10-K annual report on February 13, 2026, a 10-Q quarterly report on July 24, 2026, an 8-K current report on July 22, 2026 and a Form 4 insider filing on October 1, 2026.
What is HCSG's SEC CIK number?
HEALTHCARE SERVICES GROUP INC (HCSG)'s SEC Central Index Key (CIK) is 731012. EDGAR lists every HCSG filing under that number.
Ask anything about HCSG
The research agent reads HCSG's filings, financials, insider trades and 13F holders, then answers with sources.